SCHEMBL3784345

SCHEMBL3784345

N[C@@H](Cc1c[nH]c2ccccc12)c1n[nH]c(=O)o1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
ALDH1A1 P00352 6/20 0.55
TSHR P16473 4/20 0.55
CYP1A2 P05177 2/20 0.55
CYP2D6 P10635 2/20 0.55
CYP2C19 P33261 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
CYP3A4 P08684 1/20 0.55
MAPT P10636 4/20 0.53
TDP1 Q9NUW8 4/20 0.53
HTR2A P28223 2/20 0.51
ADRB1 P08588 1/20 0.51
HTR1A P08908 1/20 0.51
ADRA2A P08913 1/20 0.51
SLC6A2 P23975 1/20 0.51
HTR1D P28221 1/20 0.51
HTR1B P28222 1/20 0.51
HTR2C P28335 1/20 0.51
HTR1E P28566 1/20 0.51
SLC6A4 P31645 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3783713 1.00 KDM4E (0.57) KDM4EALDH1A1TSHRCYP1A2CYP2D6
SCHEMBL3783712 1.00 KDM4E (0.57) KDM4EALDH1A1TSHRCYP1A2CYP2D6
SCHEMBL4109454 0.81 MTNR1B (0.48) KDM4EALDH1A1TSHRCYP2C19NPSR1
SCHEMBL3784918 0.79 SMN1; SMN2 (0.48) KDM4EALDH1A1TSHRNPSR1MAPT
Hydrochloric Acid SCHEMBL27470772 0.76 KDM4E (0.64) KDM4EALDH1A1TSHRCYP1A2CYP2D6
SCHEMBL20511654 0.76 KDM4E (0.71) KDM4EALDH1A1TSHRCYP1A2CYP2D6
SCHEMBL30493003 0.76 KDM4E (0.71) KDM4EALDH1A1TSHRCYP1A2CYP2D6
SCHEMBL20511658 0.76 KDM4E (0.71) KDM4EALDH1A1TSHRCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL6715708 0.76 KDM4E (0.64) KDM4EALDH1A1TSHRCYP1A2CYP2D6
SCHEMBL3803107 0.75 KDM4E (0.60) KDM4EALDH1A1TSHRCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2260022-B1 SUBSTITUTED CYCLOHEXYLDIAMINES GRUENENTHAL GMBH (DE) 2017-01-04 EP disclosed
US-8357705-B2 Substituted cyclohexyldiamines GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
EP-2260022-A1 SUBSTITUTED CYCLOHEXYLDIAMINES Grünenthal GmbH (DE) 2010-12-15 EP disclosed
WO-2009118174-A1 SUBSTITUTED CYCLOHEXYLDIAMINES Grünenthal GmbH (DE) 2009-10-01 WO disclosed
US-20090247591-A1 SUBSTITUTED CYCLOHEXYLDIAMINES GRUNENTHAL GMBH (DE) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247591-A1 SUBSTITUTED CYCLOHEXYLDIAMINES OPRL1, OPRD1, OPRK1 KDM4E 2411/4885ALDH1A1 466/4885TSHR 1327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.